{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:29:57Z","timestamp":1747229397803},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12016-015-8512-9","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T08:41:12Z","timestamp":1443688872000},"page":"34-44","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms"],"prefix":"10.1007","volume":"52","author":[{"given":"Ilaria","family":"Pagnini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"8512_CR1","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman BM, Rider LG, Reed AM, Pachman LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371:2201\u20132212","journal-title":"Lancet"},{"key":"8512_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","volume":"7","author":"AB Robinson","year":"2011","unstructured":"Robinson AB, Reed AM (2011) Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol 7:664\u2013675","journal-title":"Nat Rev Rheumatol"},{"key":"8512_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"8512_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"8512_CR5","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","volume":"45","author":"VE Brown","year":"2006","unstructured":"Brown VE, Pilkington CA, Feldman BM, Davidson JE, Network for Juvenile Dermatomyositis, Paediatric Rheumatology European Society (PReS) (2006) An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford) 45:990\u2013993","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.rdc.2013.06.001","volume":"39","author":"LG Rider","year":"2013","unstructured":"Rider LG, Katz JD, Jones OY (2013) Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin N Am 39:877\u2013904","journal-title":"Rheum Dis Clin N Am"},{"key":"8512_CR7","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1002\/art.23960","volume":"58","author":"E Stringer","year":"2008","unstructured":"Stringer E, Singh-Grewal D, Feldman BM (2008) Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 58:3585\u20133592, Erratum in: Arthritis Rheum. 58:3950","journal-title":"Arthritis Rheum"},{"key":"8512_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 41:22\u201326","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C et al (2010) Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res 62:63\u201372","journal-title":"Arthritis Care Res"},{"key":"8512_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","volume":"87","author":"A Bingham","year":"2008","unstructured":"Bingham A, Mamyrova G, Rother KI et al (2008) Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of Severity. Medicine (Baltimore) 87:70\u201386","journal-title":"Medicine (Baltimore)"},{"key":"8512_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.1780250203","volume":"25","author":"WE Crowe","year":"1982","unstructured":"Crowe WE, Bove KE, Levinson JE, Hilton PK (1982) Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 25:126\u2013139","journal-title":"Arthritis Rheum"},{"key":"8512_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"8512_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/rheumatology\/ken441","volume":"48","author":"MO Harris-Love","year":"2009","unstructured":"Harris-Love MO, Shrader JA, Koziol D et al (2009) Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 48:134\u2013139","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","volume":"157","author":"P Gerami","year":"2007","unstructured":"Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD (2007) (2007), A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol 157:637\u2013644","journal-title":"Br J Dermatol"},{"key":"8512_CR15","doi-asserted-by":"publisher","first-page":"e1293","DOI":"10.1542\/peds.2010-2115","volume":"128","author":"M Ibarra","year":"2011","unstructured":"Ibarra M, Chou P, Pachman LM (2011) Ovarian teratoma mimicking features of juvenile dermatomyositis in a child. Pediatrics 128:e1293\u2013e1296","journal-title":"Pediatrics"},{"key":"8512_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","volume":"32","author":"P Morris","year":"2010","unstructured":"Morris P, Dare J (2010) Juvenile dermatomyositis as a paraneoplastic phenomenon: an update. J Pediatr Hematol Oncol 32:189\u2013191","journal-title":"J Pediatr Hematol Oncol"},{"key":"8512_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G et al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:223\u2013243","journal-title":"Medicine (Baltimore)"},{"key":"8512_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Wedderburn LR, North J et al (2008) Clinical associations of autoantibodies to a p155\/140\u00a0kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 47:324\u2013328","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Aragu\u00e1s","year":"2012","unstructured":"Trallero-Aragu\u00e1s E, Rodrigo-Pend\u00e1s J\u00c1, Selva-O\u2019Callaghan A et al (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64:523\u2013532","journal-title":"Arthritis Rheum"},{"key":"8512_CR20","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3899\/jrheum.090461","volume":"36","author":"G Espada","year":"2009","unstructured":"Espada G, Maldonado Cocco JA, Fertig N, Oddis CV (2009) Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol 36:2547\u20132551","journal-title":"J Rheumatol"},{"key":"8512_CR21","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H et al (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807\u20131814","journal-title":"Arthritis Rheum"},{"key":"8512_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360\u2013374","journal-title":"Medicine (Baltimore)"},{"key":"8512_CR23","first-page":"927","volume":"35","author":"KA Rouster-Stevens","year":"2008","unstructured":"Rouster-Stevens KA, Pachman LM (2008) Autoantibody to signal recognition particle in African American girls with juvenile polymyositis. J Rheumatol 35:927\u2013929","journal-title":"J Rheumatol"},{"key":"8512_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3899\/jrheum.101220","volume":"38","author":"N Sakurai","year":"2011","unstructured":"Sakurai N, Nagai K, Tsutsumi H, Ichimiya S (2011) Anti-CADM-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement. J Rheumatol 38:963\u2013964","journal-title":"J Rheumatol"},{"key":"8512_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K et al (2012) Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 64:513\u2013522","journal-title":"Arthritis Rheum"},{"key":"8512_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M, Mamyrova G, Targoff IN et al (2013) The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:25\u201341","journal-title":"Medicine (Baltimore)"},{"key":"8512_CR27","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","volume":"46","author":"LR Wedderburn","year":"2007","unstructured":"Wedderburn LR, McHugh NJ, Chinoy H et al (2007) HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology (Oxford) 46:1786\u20131791","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12016-013-8387-6","volume":"47","author":"S Tansley","year":"2014","unstructured":"Tansley S, Gunawardena H (2014) The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol 47:264\u2013273","journal-title":"Clin Rev Allergy Immunol"},{"key":"8512_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","volume":"53","author":"P Venalis","year":"2013","unstructured":"Venalis P, Lundberg IE (2013) Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology (Oxford) 53:397\u2013405","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","volume":"23","author":"LR Wedderburn","year":"2009","unstructured":"Wedderburn LR, Rider LG (2009) Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol 23:665\u2013678","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8512_CR31","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/art.22216","volume":"4","author":"G Mamyrova","year":"2006","unstructured":"Mamyrova G, O\u2019Hanlon TP, Monroe JB et al (2006) Immunogenetic risk and protective factors for juvenile dermatomyositis in Caicasians. Arthritis Rheum 4:3979\u20133987","journal-title":"Arthritis Rheum"},{"key":"8512_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/rheumatology\/kep248","volume":"48","author":"H Chinoy","year":"2009","unstructured":"Chinoy H, Payne D, Poulton KV et al (2009) HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology (Oxford) 48:1213\u20131217","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR33","first-page":"66","volume":"28","author":"FL Mastaglia","year":"2007","unstructured":"Mastaglia FL (2007) Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC. Acta Myol 28:66\u201371","journal-title":"Acta Myol"},{"key":"8512_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.autrev.2006.08.009","volume":"6","author":"LG Rider","year":"2007","unstructured":"Rider LG (2007) The heterogeneity of juvenile myositis. Autoimmun Rev 6:241\u2013247","journal-title":"Autoimmun Rev"},{"key":"8512_CR35","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1002\/art.23900","volume":"58","author":"H Chinoy","year":"2008","unstructured":"Chinoy H, Platt H, Lamb JA et al (2008) The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum 58:3247\u20133254","journal-title":"Arthritis Rheum"},{"key":"8512_CR36","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/art.23899","volume":"58","author":"TP O\u2019Hanlon","year":"2008","unstructured":"O\u2019Hanlon TP, Rider LG, Schiffenbauer A et al (2008) Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum 58:3239\u20133246","journal-title":"Arthritis Rheum"},{"key":"8512_CR37","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","volume":"43","author":"LM Pachman","year":"2000","unstructured":"Pachman LM, Liotta-Davis MR, Hong DK et al (2000) TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 43:2368\u20132377","journal-title":"Arthritis Rheum"},{"key":"8512_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/art.21068","volume":"53","author":"LM Pachman","year":"2005","unstructured":"Pachman LM, Lipton R, Ramsey-Goldman R et al (2005) History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 53:166\u2013172","journal-title":"Arthritis Rheum"},{"key":"8512_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/art.1780381019","volume":"38","author":"LM Pachman","year":"1995","unstructured":"Pachman LM, Litt DL, Rowley AH et al (1995) Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum 38:1513\u20131518","journal-title":"Arthritis Rheum"},{"key":"8512_CR40","first-page":"2170","volume":"294","author":"G Mamyrova","year":"2005","unstructured":"Mamyrova G, Rider LG, Haagenson L, Wong S, Brown KE (2005) Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 294:2170\u20132171","journal-title":"JAMA"},{"key":"8512_CR41","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3899\/jrheum.090953","volume":"37","author":"E Stringer","year":"2010","unstructured":"Stringer E, Bohnsack J, Bowyer SL et al (2010) Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. J Rheumatol 37:1953\u20131961","journal-title":"J Rheumatol"},{"key":"8512_CR42","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1002\/art.30475","volume":"63","author":"R Hasija","year":"2011","unstructured":"Hasija R, Pistorio A, Ravelli A et al (2011) Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. Arthritis Rheum 63:3142\u20133152","journal-title":"Arthritis Rheum"},{"key":"8512_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/acr.20171","volume":"62","author":"AM Huber","year":"2010","unstructured":"Huber AM, Giannini EH, Bowyer SL et al (2010) Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children\u2019s Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res 62:219\u2013225","journal-title":"Arthritis Care Res"},{"key":"8512_CR44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acr.20695","volume":"64","author":"AM Huber","year":"2012","unstructured":"Huber AM, Robinson AB, Reed AM et al (2012) Subcommittee of the Childhood Arthritis and Rheumatology Research Alliance Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res 64:546\u2013553","journal-title":"Arthritis Care Res"},{"key":"8512_CR45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/art.23829","volume":"59","author":"R Seshadri","year":"2008","unstructured":"Seshadri R, Feldman BM, Ilowite N, Cawkwell G, Pachman LM (2008) The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis Rheum 59:989\u2013995","journal-title":"Arthritis Rheum"},{"key":"8512_CR46","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/art.21378","volume":"52","author":"AV Ramanan","year":"2005","unstructured":"Ramanan AV, Campbell-Webster N, Ota S et al (2005) The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 52:3570\u20133578","journal-title":"Arthritis Rheum"},{"key":"8512_CR47","doi-asserted-by":"publisher","first-page":"S1042","DOI":"10.1002\/art.33342","volume":"64","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Pistorio A, Oliveira S et al (2012) A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate. Arthritis Rheum 64:S1042\u2013S1043 [Abstract]","journal-title":"Arthritis Rheum"},{"key":"8512_CR48","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1136\/ard.2011.153718","volume":"70","author":"CG Lam","year":"2011","unstructured":"Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM (2011) Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis 70:2089\u20132094","journal-title":"Ann Rheum Dis"},{"key":"8512_CR49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00296-010-1653-5","volume":"32","author":"R Dagher","year":"2012","unstructured":"Dagher R, Desjonqueres M, Duquesne A et al (2012) Mycophenolate mofetil in juvenile dermatomyositis: a case series. Rheumatol Int 32:711\u2013716","journal-title":"Rheumatol Int"},{"key":"8512_CR50","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/art.21240","volume":"52","author":"MR Wilkes","year":"2005","unstructured":"Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52:2439\u20132446","journal-title":"Arthritis Rheum"},{"key":"8512_CR51","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","volume":"27","author":"J Hassan","year":"2008","unstructured":"Hassan J, van der Net JJ, van Royen-Kerkhof A (2008) Treatment of refractory juvenile dermatomyositis with tacrolimus. Clin Rheumatol 27:1469\u20131471","journal-title":"Clin Rheumatol"},{"key":"8512_CR52","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","volume":"43","author":"P Riley","year":"2004","unstructured":"Riley P, Maillard SM, Wedderburn LR, Woo P, Murray KJ, Pilkington CA (2004) Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis A review of efficacy and safety. Rheumatology (Oxford) 43:491\u2013496","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/DDDT.S33110","volume":"6","author":"T Levine","year":"2012","unstructured":"Levine T (2012) Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series. Drug Des Devel Ther 6:133\u2013139, Erratum in: Drug Des Devel Ther. 6:163","journal-title":"Drug Des Devel Ther"},{"key":"8512_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1525-1470.2011.01501.x","volume":"28","author":"YE Chiu","year":"2011","unstructured":"Chiu YE, Co DO (2011) Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. Pediatr Dermatol 28:357\u2013367, Erratum in: Pediatr Dermatol. 28:627","journal-title":"Pediatr Dermatol"},{"key":"8512_CR55","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archderm.143.6.763","volume":"143","author":"L Chung","year":"2007","unstructured":"Chung L, Genovese MC, Fiorentino DF (2007) A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 143:763\u2013767","journal-title":"Arch Dermatol"},{"key":"8512_CR56","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324","journal-title":"Arthritis Rheum"},{"key":"8512_CR57","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/rheumatology\/keu024","volume":"53","author":"L Unger","year":"2014","unstructured":"Unger L, Kampf S, L\u00fcthke K, Aringer M (2014) Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population. Rheumatology (Oxford) 53:1630\u20131638","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR58","doi-asserted-by":"crossref","unstructured":"Basnayake C, Cash K, Blumbergs P, Limaye V (2013) Use of rituximab in histologically confirmed idiopathic inflammatory myositis: a case series. Clin Rheumatol","DOI":"10.1007\/s10067-013-2449-2"},{"key":"8512_CR59","doi-asserted-by":"crossref","unstructured":"Nalotto L, Iaccarino L, Zen M et al Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature. Immunol Res. 56:362\u201370","DOI":"10.1007\/s12026-013-8408-9"},{"key":"8512_CR60","first-page":"896","volume":"31","author":"F Mu\u00f1oz-Beamud","year":"2013","unstructured":"Mu\u00f1oz-Beamud F, Isenberg DA (2013) Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies. Clin Exp Rheumatol 31:896\u2013903","journal-title":"Clin Exp Rheumatol"},{"key":"8512_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/art.38270","volume":"66","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Bandos A, Reed AM et al (2014) Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis. Arthritis Rheumatol 66:740\u2013749","journal-title":"Arthritis Rheumatol"},{"key":"8512_CR62","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.34468","volume":"64","author":"ES Molloy","year":"2012","unstructured":"Molloy ES, Calabrese LH (2012) Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum 64:3043\u20133051","journal-title":"Arthritis Rheum"},{"key":"8512_CR63","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","volume":"47","author":"P Riley","year":"2008","unstructured":"Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA (2008) Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 47:877\u2013880","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000070852","volume":"50","author":"GJ Hengstman","year":"2003","unstructured":"Hengstman GJ, van den Hoogen FH, Barrera P et al (2003) Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol 50:10\u201315","journal-title":"Eur Neurol"},{"key":"8512_CR65","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/rheumatology\/keh539","volume":"44","author":"A Anandacoomarasamy","year":"2005","unstructured":"Anandacoomarasamy A, Howe G, Manolios N (2005) Advanced refractory polymyositis responding to infliximab. Rheumatology (Oxford) 44:562\u2013563","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR66","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/ard.2005.048744","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Schwartzman S, Kagen LJ (2006) Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients. Ann Rheum Dis 65:1233\u20131236","journal-title":"Ann Rheum Dis"},{"key":"8512_CR67","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00296-012-2653-4","volume":"33","author":"D Chen","year":"2013","unstructured":"Chen D, Wang XB, Zhou Y, Zhu XC (2013) Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review. Rheumatol Int 33:2455\u20132458","journal-title":"Rheumatol Int"},{"key":"8512_CR68","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.22477","volume":"70","author":"Muscle Study Group","year":"2011","unstructured":"Muscle Study Group (2011) A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol 70:427\u2013436","journal-title":"Ann Neurol"},{"key":"8512_CR69","first-page":"S923","volume":"58","author":"K Coyle","year":"2008","unstructured":"Coyle K, Pokrovnichka A, French K et al (2008) A Randomized, Double-Blind Placebo-Controlled Trial of Infliximab in Patients with Polymyositis and Dermatomyositis. Arthritis Rheum 58:S923\u2013S924","journal-title":"Arthritis Rheum"},{"key":"8512_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000114036","volume":"59","author":"GJ Hengstman","year":"2008","unstructured":"Hengstman GJ, De Bleecker JL, Feist E et al (2008) Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate. Eur Neurol 59:159\u2013163","journal-title":"Eur Neurol"},{"key":"8512_CR71","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/ard.2007.077974","volume":"67","author":"M Dastmalchi","year":"2008","unstructured":"Dastmalchi M, Grundtman C, Alexanderson H et al (2008) A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis 67:1670\u20131677","journal-title":"Ann Rheum Dis"},{"key":"8512_CR72","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/acr.22198","volume":"66","author":"KA Rouster-Stevens","year":"2014","unstructured":"Rouster-Stevens KA, Ferguson L, Morgan G, Huang CC, Pachman LM (2014) Pilot study of etanercept in patients with refractory juvenile dermatomyositis. Arthritis Care Res 66:783\u2013787","journal-title":"Arthritis Care Res"},{"key":"8512_CR73","first-page":"1802","volume":"33","author":"F Iannone","year":"2006","unstructured":"Iannone F, Scioscia C, Falappone PC, Covelli M, Lapadula G (2006) Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol 33:1802\u20131804","journal-title":"J Rheumatol"},{"key":"8512_CR74","first-page":"780","volume":"146","author":"R Klein","year":"2010","unstructured":"Klein R, Rosenbach M, Kim EJ, Kim B, Werth VP, Dunham J (2010) Tumor necrosis factor inhibitor-associated dermatomyositis. Arch Dermatol 146:780\u2013784","journal-title":"Arch Dermatol"},{"key":"8512_CR75","doi-asserted-by":"publisher","first-page":"179180","DOI":"10.1155\/2014\/179180","volume":"2014","author":"AM Brunasso","year":"2014","unstructured":"Brunasso AM, Aberer W, Massone C (2014) New onset of dermatomyositis\/polymyositis during anti-TNF-\u03b1 therapies: a systematic literature review. Sci World J 2014:179180","journal-title":"Sci World J"},{"key":"8512_CR76","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamadermatol.2013.5220","volume":"149","author":"SW Liu","year":"2013","unstructured":"Liu SW, Velez NF, Lam C et al (2013) Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis. JAMA Dermatol 149:1204\u20131208","journal-title":"JAMA Dermatol"},{"key":"8512_CR77","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/annrheumdis-2012-202857","volume":"73","author":"M Zong","year":"2013","unstructured":"Zong M, Dorph C, Dastmalchi M et al (2013) Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12\u00a0months follow-up. Ann Rheum Dis 73:913\u2013920","journal-title":"Ann Rheum Dis"},{"key":"8512_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2013.08.007","volume":"334","author":"ML Kosmidis","year":"2013","unstructured":"Kosmidis ML, Alexopoulos H, Tzioufas AG, Dalakas MC (2013) The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. J Neurol Sci 334:123\u2013125","journal-title":"J Neurol Sci"},{"key":"8512_CR79","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/art.24689","volume":"60","author":"N Okiyama","year":"2009","unstructured":"Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H (2009) Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A. Arthritis Rheum 60:2505\u20132512","journal-title":"Arthritis Rheum"},{"key":"8512_CR80","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/rheumatology\/ker152","volume":"50","author":"M Narazaki","year":"2011","unstructured":"Narazaki M, Hagihara K, Shima Y, Ogata A, Kishimoto T, Tanaka T (2011) Therapeutic effect of tocilizumab on two patients with polymyositis. Rheumatology (Oxford) 50:1344\u20131346","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR81","doi-asserted-by":"crossref","unstructured":"Kerola AM, Kauppi MJ (2014), Abatacept as a successful therapy for myositis-a case-based review. Clin Rheumatol","DOI":"10.1007\/s10067-014-2507-4"},{"key":"8512_CR82","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jbspin.2011.03.022","volume":"78","author":"JL Musuruana","year":"2011","unstructured":"Musuruana JL, Cavallasca JA (2011) Abatacept for treatment of refractory polymyositis. Joint Bone Spine 78:431\u2013432","journal-title":"Joint Bone Spine"},{"key":"8512_CR83","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","volume":"160","author":"B Arabshahi","year":"2012","unstructured":"Arabshahi B, Silverman RA, Jones OY, Rider LG (2012) Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis. J Pediatr 160:520\u2013522","journal-title":"J Pediatr"},{"key":"8512_CR84","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/brain\/awp104","volume":"132","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC, Rakocevic G, Schmidt J et al (2009) Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain 132:1536\u20131544","journal-title":"Brain"},{"key":"8512_CR85","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3899\/jrheum.080972","volume":"35","author":"B Thompson","year":"2008","unstructured":"Thompson B, Corris P, Miller JA, Cooper RG, Halsey JP, Isaacs JD (2008) Alemtuzumab (Campath-1H) for treatment of refractory polymyositis. J Rheumatol 35:2080\u20132082","journal-title":"J Rheumatol"},{"key":"8512_CR86","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/rheumatology\/keq429","volume":"50","author":"FA Cooles","year":"2011","unstructured":"Cooles FA, Jackson GH, Menon G, Isaacs JD (2011) Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis. Rheumatology (Oxford) 50:810\u2013812","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/ard.2008.094755","volume":"68","author":"JC Henes","year":"2009","unstructured":"Henes JC, Heinzelmann F, Wacker A et al (2009) Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantation. Ann Rheum Dis 68:447\u2013448","journal-title":"Ann Rheum Dis"},{"key":"8512_CR88","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","volume":"73","author":"BW Higgs","year":"2014","unstructured":"Higgs BW, Zhu W, Morehouse C et al (2014) A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-\u03b1 monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. Ann Rheum Dis 73:256\u2013262","journal-title":"Ann Rheum Dis"},{"key":"8512_CR89","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/rheumatology\/ket413","volume":"53","author":"X Guo","year":"2014","unstructured":"Guo X, Higgs BW, Rebelatto M et al (2014) Suppression of soluble T cell-associated proteins by an anti-interferon-\u03b1 monoclonal antibody in adult patients with dermatomyositis or polymyositis. Rheumatology (Oxford) 53:686\u2013695","journal-title":"Rheumatology (Oxford)"},{"key":"8512_CR90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/03009740903096622","volume":"39","author":"U Holzer","year":"2010","unstructured":"Holzer U, van Royen-Kerkhof A, van der Torre P et al (2010) Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. Scand J Rheumatol 39:88\u201392","journal-title":"Scand J Rheumatol"},{"key":"8512_CR91","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2141.2000.02191.x","volume":"110","author":"F Baron","year":"2000","unstructured":"Baron F, Ribbens C, Kaye O, Fillet G, Malaise M, Beguin Y (2000) Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol 110:339\u2013342","journal-title":"Br J Haematol"},{"key":"8512_CR92","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10067-005-1109-6","volume":"24","author":"K Oryoji","year":"2005","unstructured":"Oryoji K, Himeji D, Nagafuji K et al (2005) Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis. Clin Rheumatol 24:637\u2013640","journal-title":"Clin Rheumatol"},{"key":"8512_CR93","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/03009742.2013.809788","volume":"42","author":"J Storek","year":"2013","unstructured":"Storek J, LeClercq SA, Aaron SL (2013) Lack of sustained response of advanced dermatomyositis to autologous haematopoietic cell transplantation. Scand J Rheumatol 42:421\u2013422","journal-title":"Scand J Rheumatol"},{"key":"8512_CR94","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1046\/j.1365-2141.2001.02804-2.x","volume":"113","author":"S Bingham","year":"2001","unstructured":"Bingham S, Griffiths B, McGonagle D, Snowden JA, Morgan G, Emery P (2001) Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up. Br J Haematol 113:840\u2013841","journal-title":"Br J Haematol"},{"key":"8512_CR95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/10899380-000000000-00000","volume":"12","author":"HW Walling","year":"2010","unstructured":"Walling HW, Gerami P, Sontheimer RD (2010) Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management. Paediatr Drugs 12:23\u201334","journal-title":"Paediatr Drugs"},{"key":"8512_CR96","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/BOR.0b013e32834ff5cd","volume":"24","author":"S Chander","year":"2012","unstructured":"Chander S, Gordon P (2012) Soft tissue and subcutaneous calcification in connective tissue diseases. Curr Opin Rheumatol 24:158\u2013164","journal-title":"Curr Opin Rheumatol"},{"key":"8512_CR97","first-page":"408","volume":"32","author":"L Pagnini","year":"2014","unstructured":"Pagnini L, Simonini G, Giani T et al (2014) Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. Clin Exp Rheumatol 32:408\u2013409","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-015-8512-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8512-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:18:32Z","timestamp":1659093512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-015-8512-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8512"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8512-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]},"assertion":[{"value":"1 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}